Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe
<strong>Introduction<br></strong> C-reactive protein (CRP) is an important non-specific marker of both acute and chronic inflammation and can be elevated in patients with psoriatic arthritis (PsA). However, the use of CRP testing in the management of PsA can vary. This study invest...
المؤلفون الرئيسيون: | Ogdie, A, Tillett, W, Booth, N, Howell, O, Schubert, A, Peterson, S, Chakravarty, SD, Coates, LC |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer Nature
2022
|
مواد مشابهة
-
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
حسب: Coates, LC, وآخرون
منشور في: (2021) -
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
حسب: Coates, LC, وآخرون
منشور في: (2022) -
Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)
حسب: Coates, LC, وآخرون
منشور في: (2021) -
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
حسب: Helliwell, PS, وآخرون
منشور في: (2022) -
Psoriatic arthritis: prospects for the future
حسب: Hackett, S, وآخرون
منشور في: (2022)